A review and new perspective on oral bacteriophages: manifestations in the ecology of oral diseases

References

• Kinane DF, Stathopoulou PG, Papapanou PN. Periodontal diseases. Nat Rev Dis Primers. 2017;3(1):17038. doi: 10.1038/nrdp.2017.38
   PubMed Web of Science ®Google Scholar
• Lamont RJ, Koo H, Hajishengallis G. The oral microbiota: dynamic communities and host interactions. Nat Rev Microbiol. 2018;16(12):745–15. doi: 10.1038/s41579-018-0089-x
   PubMed Web of Science ®Google Scholar
• Radaic A, Kapila YL. The oralome and its dysbiosis: New insights into oral microbiome-host interactions. Comput Struct Biotechnol J. 2021;19:1335–1360. doi: 10.1016/j.csbj.2021.02.010
   PubMed Web of Science ®Google Scholar
• Baker JL, Mark Welch JL, Kauffman KM, et al. The oral microbiome: diversity, biogeography and human health. Nature Rev Microbiol. 2024;22(2):89–104. doi: 10.1038/s41579-023-00963-6
   PubMed Web of Science ®Google Scholar
• Abeles SR, Robles-Sikisaka R, Ly M, et al. Human oral viruses are personal, persistent and gender-consistent. Isme J. 2014;8(9):1753–1767. doi: 10.1038/ismej.2014.31
   PubMed Web of Science ®Google Scholar
• Baker JL, Bor B, Agnello M, et al. Ecology of the oral microbiome: beyond bacteria. Trends Microbiol. 2017;25(5):362–374. doi: 10.1016/j.tim.2016.12.012
   PubMed Web of Science ®Google Scholar
• Ly M, Abeles SR, Boehm TK, et al. Altered oral viral ecology in association with periodontal disease. MBio. 2014;5(3):e01133–14. doi: 10.1128/mBio.01133-14
   PubMed Web of Science ®Google Scholar
• Pride DT, Salzman J, Haynes M, et al. Evidence of a robust resident bacteriophage population revealed through analysis of the human salivary virome. Isme J. 2012;6(5):915–926. doi: 10.1038/ismej.2011.169
   PubMed Web of Science ®Google Scholar
• Liang G, Bushman FD. The human virome: assembly, composition and host interactions. Nature Rev Microbiol. 2021;19(8):514–527. doi: 10.1038/s41579-021-00536-5
   PubMed Web of Science ®Google Scholar
• Pinto G, Silva MD, Peddey M, et al. The role of bacteriophages in periodontal health and disease. Future Microbiol. 2016;11(10):1359–1369. doi: 10.2217/fmb-2016-0081
   PubMed Web of Science ®Google Scholar
• Kowalski J, Górska R, Cieślik M, et al. What are the potential benefits of using bacteriophages in periodontal therapy? Antibiotics. 2022;11(4):446. doi: 10.3390/antibiotics11040446
   Google Scholar
• Szafrański SP, Winkel A, Stiesch M. The use of bacteriophages to biocontrol oral biofilms. J Biotechnol. 2017;250:29–44. doi: 10.1016/j.jbiotec.2017.01.002
   PubMed Web of Science ®Google Scholar
• Wolfoviz-Zilberman A, Kraitman R, Hazan R, et al. Phage targeting Streptococcus mutans in vitro and in vivo as a caries-preventive modality. Antibiotics. 2021;10(8):1015. doi: 10.3390/antibiotics10081015
   Google Scholar
• Khalifa L, Brosh Y, Gelman D, et al. Targeting Enterococcus faecalis biofilms with phage therapy. Appl Environ Microbiol. 2015;81(8):2696–2705. doi: 10.1128/AEM.00096-15
   PubMed Web of Science ®Google Scholar
• Khalifa L, Shlezinger M, Beyth S, et al. Phage therapy against Enterococcus faecalis in dental root canals. J Oral Microbiol. 2016;8(1):32157. doi: 10.3402/jom.v8.32157
   PubMedGoogle Scholar
• Shlezinger M, Friedman M, Houri-Haddad Y, et al. Phages in a thermoreversible sustained-release formulation targeting E. faecalis in vitro and in vivo. PloS One. 2019;14(7):e0219599. doi: 10.1371/journal.pone.0219599
   PubMed Web of Science ®Google Scholar
• Steier L, de Oliveira SD, de Figueiredo JAP. Bacteriophages in dentistry—state of the art and perspectives. Dent J (Basel). 2019;7(1):6. doi: 10.3390/dj7010006
   PubMedGoogle Scholar
• Ly M, Jones MB, Abeles SR, et al. Transmission of viruses via our microbiomes. Microbiome. 2016;4(1). doi: 10.1186/s40168-016-0212-z
   Google Scholar
• Naidu M, Robles-Sikisaka R, Abeles SR, et al. Characterization of bacteriophage communities and CRISPR profiles from dental plaque. BMC Microbiol. 2014;14(1):175. doi: 10.1186/1471-2180-14-175
   PubMedGoogle Scholar
• Pérez-Brocal V, Moya A. The analysis of the oral DNA virome reveals which viruses are widespread and rare among healthy young adults in Valencia (Spain). PLOS ONE. 2018;13(2):e0191867. doi: 10.1371/journal.pone.0191867
   PubMed Web of Science ®Google Scholar
• Weinbauer MG. Ecology of prokaryotic viruses. FEMS Microbiol Rev. 2004;28(2):127–181. doi: 10.1016/j.femsre.2003.08.001
   PubMed Web of Science ®Google Scholar
• Oliveira H, São-José C, Azeredo J. Phage-derived peptidoglycan degrading enzymes: challenges and future prospects for in vivo therapy. Viruses. 2018;10(6):292. doi: 10.3390/v10060292
   PubMed Web of Science ®Google Scholar
• Mirzaei MK, Maurice CF. Menage a trois in the human gut: interactions between host, bacteria and phages. Nat Rev Microbiol. 2017;15(7):397–408. doi: 10.1038/nrmicro.2017.30
   PubMed Web of Science ®Google Scholar
• Canchaya C, Fournous G, Chibani-Chennoufi S, et al. Phage as agents of lateral gene transfer. Curr Opin Microbiol. 2003;6(4):417–424. doi: 10.1016/S1369-5274(03)00086-9
   PubMed Web of Science ®Google Scholar
• Abeles SR, Pride DT. Molecular bases and role of viruses in the human microbiome. J Mol Biol. 2014;426(23):3892–3906. doi: 10.1016/j.jmb.2014.07.002
   PubMed Web of Science ®Google Scholar
• Teklemariam AD, Al-Hindi RR, Qadri I, et al. The battle between bacteria and bacteriophages: a conundrum to their immune system. Antibiotics. 2023;12(2):381. doi: 10.3390/antibiotics12020381
   Google Scholar
• Hasan M, Ahn J. Evolutionary dynamics between phages and bacteria as a possible approach for designing effective phage therapies against antibiotic-resistant bacteria. Antibiotics. 2022;11(7):915. doi: 10.3390/antibiotics11070915
   Google Scholar
• Safari F, Sharifi M, Farajnia S, et al. The interaction of phages and bacteria: the co-evolutionary arms race. Crit Rev Biotechnol. 2020;40(2):119–137. doi: 10.1080/07388551.2019.1674774
   PubMed Web of Science ®Google Scholar
• Hampton HG, Watson BNJ, Fineran PC. The arms race between bacteria and their phage foes. Nature. 2020;577(7790):327–336. doi: 10.1038/s41586-019-1894-8
   PubMed Web of Science ®Google Scholar
• Malone LM, Birkholz N, Fineran PC. Conquering CRISPR: how phages overcome bacterial adaptive immunity. Curr Opin Biotechnol. 2021;68:30–36. doi: 10.1016/j.copbio.2020.09.008
   PubMed Web of Science ®Google Scholar
• Szafranski SP, Slots J, Stiesch M. The human oral phageome. Periodontol 2000. 2021;86(1):79–96. doi: 10.1111/prd.12363
   PubMed Web of Science ®Google Scholar
• Zou G, He L, Rao J, et al. Improving the safety and efficacy of phage therapy from the perspective of phage-mammal interactions. FEMS Microbiol Rev. 2023;47(4). doi: 10.1093/femsre/fuad042
   PubMed Web of Science ®Google Scholar
• Hansen MF, Svenningsen SL, Røder HL, et al. Big impact of the tiny: bacteriophage–bacteria interactions in biofilms. Trends Microbiol. 2019;27(9):739–752. doi: 10.1016/j.tim.2019.04.006
   PubMed Web of Science ®Google Scholar
• Correa AMS, Howard-Varona C, Coy SR, et al. Revisiting the rules of life for viruses of microorganisms. Nature Rev Microbiol. 2021;19(8):501–513. doi: 10.1038/s41579-021-00530-x
   PubMed Web of Science ®Google Scholar
• Peng X, Cheng L, You Y, et al. Oral microbiota in human systematic diseases. Int J Oral Sci. 2022;14(1):14. doi: 10.1038/s41368-022-00163-7
   PubMed Web of Science ®Google Scholar
• Bull JJ, Christensen K, Scott C, et al. Phage-bacterial dynamics with spatial structure: self organization around phage sinks can promote increased cell densities. Antibiotics. 2018;7(1):8. doi: 10.3390/antibiotics7010008
   Web of Science ®Google Scholar
• Silpe JE, Bassler BL. A host-produced quorum-sensing autoinducer controls a phage lysis-lysogeny decision. Cell. 2019;176(1–2):268–280.e13. doi: 10.1016/j.cell.2018.10.059
   PubMed Web of Science ®Google Scholar
• Abedon ST. Ecology and evolutionary biology of hindering phage therapy: the phage tolerance vs. phage resistance of bacterial biofilms. Antibiotics. 2023;12(2):245. doi: 10.3390/antibiotics12020245
   Google Scholar
• Willner D, Furlan M, Schmieder R, et al. Metagenomic detection of phage-encoded platelet-binding factors in the human oral cavity. Proc Natl Acad Sci, USA. 2011;108(supplement_1):4547–4553. doi: 10.1073/pnas.1000089107
   PubMedGoogle Scholar
• Shlezinger M, Khalifa L, Houri-Haddad Y, et al. Phage therapy: a new horizon in the antibacterial treatment of oral pathogens. Curr Top Med Chem. 2017;17(10):1199–1211. doi: 10.2174/1568026616666160930145649
   PubMed Web of Science ®Google Scholar
• Martínez A, Kuraji R, Kapila YL. The human oral virome: Shedding light on the dark matter. Periodontol 2000. 2021;87(1):282–298. doi: 10.1111/prd.12396
   PubMed Web of Science ®Google Scholar
• Azam AH, Tan X-E, Veeranarayanan S, et al. Bacteriophage technology and modern medicine. Antibiotics. 2021;10(8):999. doi: 10.3390/antibiotics10080999
   Google Scholar
• Gangwar M, Rastogi S, Singh D, et al. Immunological and safety profile of bacteriophage therapy: A pre-clinical study. J Appl Microbiol. 2022;133(3):1446–1460. doi: 10.1111/jam.15642
   PubMed Web of Science ®Google Scholar
• Rappo U, Kahan-Hanum M, Ussery X, et al. 126 a phase 1b/2a randomized, double-blind, placebo-controlled, multicenter study evaluating nebulized phage therapy in people with cystic fibrosis with chronic Pseudomonas aeruginosa pulmonary infection. J Cystic Fibrosis. 2023;22:S66–S67. doi: 10.1016/S1569-1993(23)01059-7
   PubMedGoogle Scholar
• Chan B, Kortright K, Stanley G, et al. 41 CYstic Fibrosis bacterioPhage study at Yale (CYPHY). J Cystic Fibrosis. 2023;22:22. doi: 10.1016/S1569-1993(23)00976-1
   Google Scholar
• Sarker SA, Sultana S, Reuteler G, et al. Oral phage therapy of acute bacterial diarrhea with two coliphage preparations: a randomized trial in children from Bangladesh. EBioMedicine. 2016;4:124–137. doi: 10.1016/j.ebiom.2015.12.023
   PubMed Web of Science ®Google Scholar
• Sarker SA, Berger B, Deng Y, et al. Oral application of Escherichia coli bacteriophage: safety tests in healthy and diarrheal children from Bangladesh. Environ Microbiol. 2017;19(1):237–250. doi: 10.1111/1462-2920.13574
   PubMed Web of Science ®Google Scholar
• Karn SL, Bhartiya SK, Pratap A, et al. A randomized, placebo-controlled, double-blind clinical trial of bacteriophage cocktails in chronic wound infections. Int J Low Extrem Wounds. 2024:15347346231226342. doi: 10.1177/15347346231226342
   Web of Science ®Google Scholar
• Jault P, Leclerc T, Jennes S, et al. Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial. Lancet Infect Dis. 2019;19(1):35–45. doi: 10.1016/S1473-3099(18)30482-1
   PubMed Web of Science ®Google Scholar
• Fedorov E, Samokhin A, Kozlova Y, et al. Short-term outcomes of phage-antibiotic combination treatment in adult patients with periprosthetic hip joint infection. Viruses. 2023;15(2):499. doi: 10.3390/v15020499
   PubMed Web of Science ®Google Scholar
• Doub JB, Ng VY, Wilson E, et al. Successful treatment of a Recalcitrant Staphylococcus epidermidis prosthetic knee infection with intraoperative bacteriophage therapy. Pharmaceuticals. 2021;14(3):231. doi: 10.3390/ph14030231
   Web of Science ®Google Scholar
• Wortelboer K, de Jonge PA, Scheithauer TPM, et al. Phage-microbe dynamics after sterile faecal filtrate transplantation in individuals with metabolic syndrome: a double-blind, randomised, placebo-controlled clinical trial assessing efficacy and safety. Nat Commun. 2023;14(1). doi: 10.1038/s41467-023-41329-z
   PubMed Web of Science ®Google Scholar
• Michelson D, Grundman M, Magnuson K, et al. Randomized, placebo controlled trial of Npt088, a phage-derived, amyloid-targeted treatment for Alzheimer’s disease. J prev Alzheimer’s dis. 2019:1–4. doi: 10.14283/jpad.2019.37
   Web of Science ®Google Scholar
• Hesse S, Adhya S. Phage therapy in the twenty-first century: facing the decline of the antibiotic era; is it finally time for the age of the phage? Annu Rev Microbiol. 2019;73(1):155–174. doi: 10.1146/annurev-micro-090817-062535
   PubMedGoogle Scholar
• Hatfull GF, Dedrick RM, Schooley RT. Phage therapy for antibiotic-resistant bacterial infections. Annu Rev Med. 2022;73(1):197–211. doi: 10.1146/annurev-med-080219-122208
   PubMedGoogle Scholar
• Barclay CW, Spence D, Laird WRE. Intra‐oral temperatures during function. J Oral Rehabil. 2005;32(12):886–894. doi: 10.1111/j.1365-2842.2005.01509.x
   PubMed Web of Science ®Google Scholar
• Banar M, Rokaya D, Azizian R, et al. Oral bacteriophages: metagenomic clues to interpret microbiomes. PeerJ. 2024;12:12. doi: 10.7717/peerj.16947
   Web of Science ®Google Scholar
• Michaud DS, Fu Z, Shi J, et al. Periodontal disease, tooth loss, and cancer risk. Epidemiol Rev. 2017;39(1):49–58. doi: 10.1093/epirev/mxx006
   PubMed Web of Science ®Google Scholar
• Maisonneuve P, Amar S, Lowenfels AB. Periodontal disease, edentulism, and pancreatic cancer: a meta-analysis. Ann Oncol. 2017;28(5):985–995. doi: 10.1093/annonc/mdx019
   PubMed Web of Science ®Google Scholar
• Loos BG, Van Dyke TE. The role of inflammation and genetics in periodontal disease. Periodontol 2000. 2020;83(1):26–39. doi: 10.1111/prd.12297
   PubMed Web of Science ®Google Scholar
• Chen C, Feng P, Slots J. Herpesvirus-bacteria synergistic interaction in periodontitis. Periodontol 2000. 2020;82(1):42–64. doi: 10.1111/prd.12311
   PubMed Web of Science ®Google Scholar
• Imai K, Ogata Y. How does Epstein–Barr Virus contribute to chronic periodontitis? IJMS. 2020;21(6):1940. doi: 10.3390/ijms21061940
   Google Scholar
• Contreras A, Botero JE, Slots J. Biology and pathogenesis of cytomegalovirus in periodontal disease. Periodontol 2000. 2014;64(1):40–56. doi: 10.1111/j.1600-0757.2012.00448.x
   PubMed Web of Science ®Google Scholar
• Yost S, Duran-Pinedo AE, Teles R, et al. Functional signatures of oral dysbiosis during periodontitis progression revealed by microbial metatranscriptome analysis. Genome Med. 2015;7(1). doi: 10.1186/s13073-015-0153-3
   Google Scholar
• Hajishengallis G, Darveau RP, Curtis MA. The keystone-pathogen hypothesis. Nat Rev Microbiol. 2012;10(10):717–725. doi: 10.1038/nrmicro2873
   PubMed Web of Science ®Google Scholar
• Matrishin CB, Haase EM, Dewhirst FE, et al. Phages are unrecognized players in the ecology of the oral pathogen Porphyromonas gingivalis. Microbiome. 2023;11(1). doi: 10.1186/s40168-023-01607-w
   PubMed Web of Science ®Google Scholar
• Holt SC, Ebersole JL. Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia: the ‘red complex’, a prototype polybacterial pathogenic consortium in periodontitis. Periodontol 2000. 2005;38(1):72–122. doi: 10.1111/j.1600-0757.2005.00113.x
   PubMedGoogle Scholar
• Mitchell HL, Dashper SG, Catmull DV, et al. Treponema denticola biofilm-induced expression of a bacteriophage, toxin–antitoxin systems and transposases. Microbiology. 2010;156(3):774–788. doi: 10.1099/mic.0.033654-0
   PubMedGoogle Scholar
• Brennan CA, Garrett WS. Fusobacterium nucleatum - symbiont, opportunist and oncobacterium. Nat Rev Microbiol. 2019;17(3):156–166. doi: 10.1038/s41579-018-0129-6
   PubMed Web of Science ®Google Scholar
• Machuca P, Daille L, Vinés E, et al. Isolation of a novel bacteriophage specific for the periodontal pathogen Fusobacterium nucleatum. Appl Environ Microbiol. 2010;76(21):7243–7250. doi: 10.1128/AEM.01135-10
   PubMed Web of Science ®Google Scholar
• Kabwe M, Brown TL, Dashper S, et al. Genomic, morphological and functional characterisation of novel bacteriophage FNU1 capable of disrupting Fusobacterium nucleatum biofilms. Sci Rep. 2019;9(1):9107. doi: 10.1038/s41598-019-45549-6
   PubMedGoogle Scholar
• Darveau RP. Periodontitis: a polymicrobial disruption of host homeostasis. Nat Rev Microbiol. 2010;8(7):481–490. doi: 10.1038/nrmicro2337
   PubMed Web of Science ®Google Scholar
• Vega BA, Belinka BA Jr., Kachlany SC. Aggregatibacter actinomycetemcomitans Leukotoxin (LtxA; Leukothera®): Mechanisms of action and therapeutic applications. Toxins (Basel). 2019;11(9):489. doi: 10.3390/toxins11090489
   PubMed Web of Science ®Google Scholar
• Castillo-Ruiz M, Vinés ED, Montt C, et al. Isolation of a Novel Aggregatibacter actinomycetemcomitans Serotype b bacteriophage capable of Lysing Bacteria within a biofilm. Appl environ microbiol. 2011;77(9):3157–3159. doi: 10.1128/AEM.02115-10
   PubMed Web of Science ®Google Scholar
• Delisle AL, Barcak GJ, Guo M. Isolation and expression of the lysis genes of actinomyces naeslundii phage av-1. Appl Environ Microbiol. 2006;72(2):1110–1117. doi: 10.1128/AEM.72.2.1110-1117.2006
   PubMed Web of Science ®Google Scholar
• Zhang Y, Shan T-L, Li F, et al. A novel phage from periodontal pockets associated with chronic periodontitis. Vir Gen. 2019;55(3):381–393. doi: 10.1007/s11262-019-01658-y
   PubMed Web of Science ®Google Scholar
• Endo A, Watanabe T, Ogata N, et al. Comparative genome analysis and identification of competitive and cooperative interactions in a polymicrobial disease. Isme J. 2015;9(3):629–642. doi: 10.1038/ismej.2014.155
   PubMed Web of Science ®Google Scholar
• Yokogawa T, Nagano K, Fujita M, et al. Characterization of a Treponema denticola ATCC 35405 mutant strain with mutation accumulation, including a lack of phage-derived genes. PloS One. 2022;17(6):e0270198. doi: 10.1371/journal.pone.0270198
   PubMed Web of Science ®Google Scholar
• Szafranski SP, Kilian M, Yang I, et al. Diversity patterns of bacteriophages infecting aggregatibacter and Haemophilus species across clades and niches. Isme J. 2019;13(10):2500–2522. doi: 10.1038/s41396-019-0450-8
   PubMed Web of Science ®Google Scholar
• Tang-Siegel GG, Chen C, Mintz KP. Increased sensitivity of Aggregatibacter actinomycetemcomitans to human serum is mediated by induction of a bacteriophage. Mol Oral Microbiol. 2023;38(1):58–70. doi: 10.1111/omi.12378
   PubMed Web of Science ®Google Scholar
• Wang J, Gao Y, Zhao F. Phage-bacteria interaction network in human oral microbiome. Environ Microbiol. 2016;18(7):2143–2158. doi: 10.1111/1462-2920.12923
   PubMed Web of Science ®Google Scholar
• Ferri M, Ranucci E, Romagnoli P, et al. Antimicrobial resistance: a global emerging threat to public health systems. Crit Rev Food Sci Nutr. 2017;57(13):2857–2876. doi: 10.1080/10408398.2015.1077192
   PubMed Web of Science ®Google Scholar
• Abdulkareem A, Abdulbaqi H, Gul S, et al. Classic vs. Novel antibacterial approaches for eradicating dental biofilm as adjunct to periodontal debridement: an evidence-based overview. Antibiotics. 2021;11(1):9. doi: 10.3390/antibiotics11010009
   Google Scholar
• Amankwah S, Abdella K, Kassa T. Bacterial biofilm destruction: a focused review on the recent use of phage-based strategies with other antibiofilm agents. Nanotechnol Sci Appl. 2021;14:161–177. doi: 10.2147/NSA.S325594
   PubMed Web of Science ®Google Scholar
• Yang Y, Du H, Zou G, et al. Encapsulation and delivery of phage as a novel method for gut flora manipulation in situ: A review. J Controlled Release. 2023;353:634–649. doi: 10.1016/j.jconrel.2022.11.048
   PubMed Web of Science ®Google Scholar
• Jakubovics NS, Yassin SA, Rickard AH. Community Interactions of Oral Streptococci. Adv Appl Microbiol. 2014(87):43–110.
   PubMed Web of Science ®Google Scholar
• Baker JL, Morton JT, Dinis M, et al. Deep metagenomics examines the oral microbiome during dental caries, revealing novel taxa and co-occurrences with host molecules. Genome Res. 2021;31(1):64–74. doi: 10.1101/gr.265645.120
   PubMed Web of Science ®Google Scholar
• van der Ploeg JR. Genome sequence of Streptococcus mutans bacteriophage M102. FEMS Microbiol Lett. 2007;275(1):130–138. doi: 10.1111/j.1574-6968.2007.00873.x
   PubMed Web of Science ®Google Scholar
• Dalmasso M, de Haas E, Neve H, et al. Isolation of a novel phage with activity against Streptococcus mutans biofilms. PloS One. 2015;10(9):e0138651. doi: 10.1371/journal.pone.0138651
   PubMed Web of Science ®Google Scholar
• Ben-Zaken H, Kraitman R, Coppenhagen-Glazer S, et al. Isolation and characterization of Streptococcus mutans phage as a possible treatment agent for caries. Viruses. 2021;13(5):825. doi: 10.3390/v13050825
   PubMed Web of Science ®Google Scholar
• Tang G, Samaranayake LP, Yip H-K, et al. Direct detection of Actinomyces spp. From infected root canals in a Chinese population: a study using PCR-based, oligonucleotide-DNA hybridization technique. J Dent. 2003;31(8):559–568. doi: 10.1016/S0300-5712(03)00112-X
   PubMed Web of Science ®Google Scholar
• Shen M, Yang Y, Shen W, et al. A linear plasmid-like prophage of actinomyces odontolyticus promotes biofilm assembly. Appl Environ Microbiol. 2018;84(17). doi: 10.1128/AEM.01263-18
   Web of Science ®Google Scholar
• Guo L, McLean JS, Yang Y, et al. Precision-guided antimicrobial peptide as a targeted modulator of human microbial ecology. Proc Natl Acad Sci U S A. 2015;112(24):7569–7574. doi: 10.1073/pnas.1506207112
   PubMed Web of Science ®Google Scholar
• Xu J, Yang H, Bi Y, et al. Activity of the chimeric lysin ClyR against common gram-positive oral microbes and its anticaries efficacy in rat models. Viruses. 2018;10(7):380. doi: 10.3390/v10070380
   PubMed Web of Science ®Google Scholar
• Jiang W, Wang Y, Luo J, et al. Antimicrobial Peptide GH12 Prevents Dental Caries by Regulating Dental Plaque Microbiota. Appl Environ Microbiol. 2020;86(14). doi: 10.1128/AEM.00527-20
   Web of Science ®Google Scholar
• Gong T, Tang B, Zhou X, et al. Genome editing in Streptococcus mutans through self-targeting CRISPR arrays. Mol Oral Microbiol. 2018;33(6):440–449. doi: 10.1111/omi.12247
   PubMed Web of Science ®Google Scholar
• Rajabi Z, Soltan Dallal MM, Afradi MR, et al. Comparison of the effect of extracted bacteriocin and lytic bacteriophage on the expression of biofilm associated genes in Streptococcus mutans. Adv Mater Sci Eng. 2022;2022:1–7. doi: 10.1155/2022/5035280
   Web of Science ®Google Scholar
• Xiang D, Dong P-T, Cen L, et al. Antagonistic interaction between two key endodontic pathogens Enterococcus faecalis and Fusobacterium nucleatum. J Oral Microbiol. 2023;15(1):2149448. doi: 10.1080/20002297.2022.2149448
   PubMed Web of Science ®Google Scholar
• Siqueira JF Jr., Rocas IN. Present status and future directions: Microbiology of endodontic infections. Int Endod J. 2022;55(S3):512–530. doi: 10.1111/iej.13677
   PubMedGoogle Scholar
• Deng Z, Lin B, Liu F, et al. Role of Enterococcus faecalis in refractory apical periodontitis: from pathogenicity to host cell response. J Oral Microbiol. 2023;15(1):2184924. doi: 10.1080/20002297.2023.2184924
   PubMed Web of Science ®Google Scholar
• Vehreschild MJGT, Haverkamp M, Biehl LM, et al. Vancomycin-resistant enterococci (VRE): a reason to isolate? Infection. 2019;47(1):7–11. doi: 10.1007/s15010-018-1202-9
   PubMed Web of Science ®Google Scholar
• Barros J, Melo LDR, Poeta P, et al. Lytic bacteriophages against multidrug-resistant Staphylococcus aureus, Enterococcus faecalis and Escherichia coli isolates from orthopaedic implant-associated infections. Int J Antimicrob Agents. 2019;54(3):329–337. doi: 10.1016/j.ijantimicag.2019.06.007
   PubMed Web of Science ®Google Scholar
• Pazhouhnia S, Bouzari M, Arbabzadeh-Zavareh F. Isolation, characterization and complete genome analysis of a novel bacteriophage vB_efaS-SRH2 against Enterococcus faecalis isolated from periodontitis patients. Sci Rep. 2022;12(1). doi: 10.1038/s41598-022-16939-0
   PubMed Web of Science ®Google Scholar
• Pradal I, Casado A, Del Rio B, et al. Enterococcus faecium Bacteriophage vB_efah_163, a new member of the Herelleviridae family, reduces the mortality associated with an E. faecium vanR clinical isolate in a Galleria mellonella animal model. Viruses. 2023;15(1):179. doi: 10.3390/v15010179
   PubMed Web of Science ®Google Scholar
• Melo LDR, Ferreira R, Costa AR, et al. Efficacy and safety assessment of two enterococci phages in an in vitro biofilm wound model. Sci Rep. 2019;9(1). doi: 10.1038/s41598-019-43115-8
   Google Scholar
• Topka-Bielecka G, Bloch S, Nejman-Faleńczyk B, et al. Characterization of the Bacteriophage vB_efaS-271 Infecting Enterococcus faecalis. IJMS. 2020;21(17):6345. doi: 10.3390/ijms21176345
   Google Scholar
• Topka-Bielecka G, Nejman-Faleńczyk B, Bloch S, et al. Phage–bacteria interactions in potential applications of bacteriophage vB_efaS-271 against Enterococcus faecalis. Viruses. 2021;13(2):318. doi: 10.3390/v13020318
   PubMed Web of Science ®Google Scholar
• El-Telbany M, El-Didamony G, Askora A, et al. Bacteriophages to control multi-drug resistant Enterococcus faecalis infection of dental root canals. Microorganisms. 2021;9(3):517. doi: 10.3390/microorganisms9030517
   PubMed Web of Science ®Google Scholar
• Delisle AL, Nauman RK, Minah GE. Isolation of a bacteriophage for actinomyces viscosus. Infect Immun. 1978;20(1):303–306. doi: 10.1128/iai.20.1.303-306.1978
   PubMed Web of Science ®Google Scholar
• Zhang W, Mi Z, Yin X, et al. Characterization of Enterococcus faecalis phage IME-EF1 and its endolysin. PloS One. 2013;8(11):e80435. doi: 10.1371/journal.pone.0080435
   PubMed Web of Science ®Google Scholar
• Lossouarn J, Briet A, Moncaut E, et al. Enterococcus faecalis Countermeasures Defeat a Virulent Picovirinae Bacteriophage. Viruses. 2019;11(1):48. doi: 10.3390/v11010048
   PubMed Web of Science ®Google Scholar
• Gong P, Cheng M, Li X, et al. Characterization of Enterococcus faecium bacteriophage IME-EFm5 and its endolysin LysEFm5. Virology. 2016;492:11–20. doi: 10.1016/j.virol.2016.02.006
   PubMed Web of Science ®Google Scholar
• Xing S, Zhang X, Sun Q, et al. Complete genome sequence of a novel, virulent Ahjdlikevirus bacteriophage that infects Enterococcus faecium. Arch Virol. 2017;162(12):3843–3847. doi: 10.1007/s00705-017-3503-1
   PubMed Web of Science ®Google Scholar
• Buzikov RM, Kazantseva OA, Piligrimova EG, et al. Bacteriolytic potential of Enterococcus Phage iF6 Isolated from “Sextaphag(®)” Therapeutic Phage Cocktail and properties of its endolysins, Gp82 and Gp84. Viruses. 2023;15(3):767.
   PubMed Web of Science ®Google Scholar
• Khalifa L, Gelman D, Shlezinger M, et al. Defeating Antibiotic- and Phage-Resistant Enterococcus faecalis Using a Phage Cocktail in vitro and in a Clot Model. Front Microbiol. 2018;9:9. doi: 10.3389/fmicb.2018.00326
   PubMed Web of Science ®Google Scholar
• Ho K, Huo W, Pas S, et al. Loss-of-Function Mutations in epaR Confer Resistance to ϕNPV1 Infection in Enterococcus faecalis OG1RF. Antimicrob Agents Chemother. 2018;62(10). doi: 10.1128/AAC.00758-18
   Web of Science ®Google Scholar
• Wandro S, Ghatbale P, Attai H, et al. Phage Cocktails can Prevent the Evolution of Phage-Resistant Enterococcus.
   Google Scholar
• Shlezinger M, Coppenhagen-Glazer S, Gelman D, et al. Eradication of Vancomycin-Resistant Enterococci by Combining Phage and Vancomycin. Viruses. 2019;11(10):954. doi: 10.3390/v11100954
   PubMed Web of Science ®Google Scholar
• Canfield GS, Chatterjee A, Espinosa J, et al. Lytic Bacteriophages Facilitate Antibiotic Sensitization of Enterococcus faecium. Antimicrob Agents Chemother. 2021;65(5). doi: 10.1128/AAC.00143-21
   PubMed Web of Science ®Google Scholar
• Cheng M, Zhang Y, Li X, et al. Endolysin LysEF-P10 shows potential as an alternative treatment strategy for multidrug-resistant Enterococcus faecalis infections. Sci Rep. 2017;7(1):10164. doi: 10.1038/s41598-017-10755-7
   PubMedGoogle Scholar
• Proença D, Velours C, Leandro C, et al. A two-component, multimeric endolysin encoded by a single gene. Mol Microbiol. 2015;95(5):739–753. doi: 10.1111/mmi.12857
   PubMed Web of Science ®Google Scholar
• Xu X, Zhang D, Zhou B, et al. Structural and biochemical analyses of the tetrameric cell binding domain of Lys170 from enterococcal phage F170/08. Eur Biophys J. 2021;50(5):721–729. doi: 10.1007/s00249-021-01511-x
   PubMed Web of Science ®Google Scholar
• Chang C, Geng F, Shi X, et al. The prevalence rate of periodontal pathogens and its association with oral squamous cell carcinoma. Appl Microbiol Biotechnol. 2019;103(3):1393–1404. doi: 10.1007/s00253-018-9475-6
   PubMed Web of Science ®Google Scholar
• Li R, Xiao L, Gong T, et al. Role of oral microbiome in oral oncogenesis, tumor progression, and metastasis. Mol Oral Microbiol. 2023;38(1):9–22. doi: 10.1111/omi.12403
   PubMed Web of Science ®Google Scholar
• Nwizu N, Wactawski‐Wende J, Genco RJ. Periodontal disease and cancer: Epidemiologic studies and possible mechanisms. Periodontol 2000. 2020;83(1):213–233. doi: 10.1111/prd.12329
   PubMed Web of Science ®Google Scholar
• Castellsagué X, Alemany L, Quer M, et al. HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients. JNCI. 2016;108(6):djv403. doi: 10.1093/jnci/djv403
   PubMedGoogle Scholar
• Podlacha M, Grabowski Ł, Kosznik-Kawśnicka K, et al. Interactions of bacteriophages with animal and human organisms—safety issues in the light of phage therapy. Int J Mol Sci. 2021;22(16):8937. doi: 10.3390/ijms22168937
   PubMed Web of Science ®Google Scholar
• Zhai L, Yadav R, Kunda NK, et al. Oral immunization with bacteriophage MS2-L2 VLPs protects against oral and genital infection with multiple HPV types associated with head & neck cancers and cervical cancer. Antiviral Res. 2019;166:56–65. doi: 10.1016/j.antiviral.2019.03.012
   PubMed Web of Science ®Google Scholar
• Ghosh D, Peng X, Leal J, et al. Peptides as drug delivery vehicles across biological barriers. J Pharm Invest. 2018;48(1):89–111. doi: 10.1007/s40005-017-0374-0
   PubMedGoogle Scholar